GlaxoSmithKline PLC GSK:NYSE (Depositary Receipt)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 45.77 | 0.52 1.15% | 5.80% | 36,646 | 7.0M |
Latest News Headlines for GlaxoSmithKline PLC
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 8, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Mylan, Inc. (NASDAQ: MYL), Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), GlaxoSmithKline plc (NYSE: GSK), Cigna Corp. (NYSE: CI) and WellPoint Inc. (NYSE: WLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7013-100free.
CHICAGO, Oct. 1, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DISCA, GSK, ILMN, TK and GPOR. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Company Background
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK's principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 45.08 |
| Previous Close | 45.77 |
| Day High | -- |
| Day Low | -- |
| 52 Week High | 2/18/2014 | 56.73 |
| 52 Week Low | 10/8/2014 | 45.04 |
| % Off 52 Week High | -19.32% |
| % Off 52 Week Low | 1.62% |
| Beta (5 Yr) | 0.6 |
| Volatility Avg | 10/8/2014 | 15.95 |
| 10-Day Avg. Volume | 6,990,340 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | 3.14 |
|---|---|
| P/E Ratio | 6/30/2014 | 14.6 |
| Market Cap | Large Cap | 111.0B |
| Shares Outstanding | 2.42B |
| Float | 2.4B |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | 5.80% |
|---|---|
| Ex-Date | 8/6/2014 |
| Dividend Announcement | 7/23/2014 |
| Date of Record | 8/8/2014 |
| Payable | $0.6482 - QRTR |
| Payable Date | 10/2/2014 |
Peers Information HelpGSK GlaxoSmithKline PLC vs. Peers
| Peers | |
|---|---|
GSK GlaxoSmithKline PLC | -14.27% |
The Procter & Gamble Company | 3.40% |
Johnson & Johnson | 14.54% |
Pfizer Inc. | -4.08% |
Merck & Co., Inc. | 20.24% |
GSK GlaxoSmithKline PLC | 5.80% |
The Procter & Gamble Company | 3.06% |
Johnson & Johnson | 2.67% |
Pfizer Inc. | 3.54% |
Merck & Co., Inc. | 2.92% |
GSK GlaxoSmithKline PLC | 1.15% |
The Procter & Gamble Company | 1.23% |
Johnson & Johnson | 2.46% |
Pfizer Inc. | 2.05% |
Merck & Co., Inc. | 2.94% |